Related Experiment Video
Updated: Apr 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
The unexpected evolution of basic science studies about cyclic nucleotide action into a treatment for erectile
1From the Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232 jackie.corbin@vanderbilt.edu.
Basic science research into cyclic nucleotides led to the development of phosphodiesterase type 5 (PDE5) inhibitors. These discoveries now treat erectile dysfunction, improving patient health outcomes.
Area of Science:
- Biochemistry and Pharmacology
- Molecular Biology
Background:
- Exploration of cyclic nucleotide signaling pathways.
- Unpredictable scientific discoveries in the cyclic nucleotide field.
Discussion:
- The author's role in key discoveries.
- The development pathway of phosphodiesterase type 5 (PDE5) inhibitors.
- The link between basic science and clinical applications.
Key Insights:
- Basic science research is crucial for medical advancements.
- Cyclic nucleotide research paved the way for erectile dysfunction treatments.
- Phosphodiesterase type 5 (PDE5) inhibitors offer therapeutic benefits.
Outlook:
- Continued exploration of cyclic nucleotide signaling.
- Potential for further therapeutic applications derived from basic science.
- The unpredictable nature of scientific discovery driving innovation.
More Related Videos
07:15Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025
02:21Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Antihypertensive Drugs: Vasodilators